Opinion

Video

DESTINY-Lung01 & DESTINY-Lung02: T-DXd in Metastatic HER2-Mutated NSCLC

Lyudmila A. Bazhenova, MD, and D. Ross Camidge, MD, PhD, review the DESTINY-Lung01 and DESTINY-Lung02 trials, and the panel provides its impressions of the data.

Related Videos
Alexey Danilov, MD, PhD
Tycel Phillips, MD
5 KOLs are featured in this panel.
5 KOLs are featured in this panel.
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
A panel of 5 experts on breast cancer
A panel of 5 experts on breast cancer